(R)-69

出自Local Chinese Wikipedia
跳至導覽 跳至搜尋
(R)-69
File:(R)-69.svg
臨床資料
其他名稱R-69; 3IQ
藥物類別Non-hallucinogenic Serotonin 5-HT2A receptor agonist
識別資訊
  • 3-[(5R)-5-methyl-1,2,5,6-tetrahydropyridin-3-yl]-1H-pyrrolo[2,3-b]pyridine
CAS號2765652-48-8  checkY
PubChem CID
ChemSpider
UNII
ChEMBL
PDB配體ID
化學資訊
化學式C13H15N3
摩爾質量213.28 g·mol−1
3D模型(JSmol
  • C[C@@H]1C=C(CNC1)c1c[NH]c2ncccc12
  • InChI=1S/C13H15N3/c1-9-5-10(7-14-6-9)12-8-16-13-11(12)3-2-4-15-13/h2-5,8-9,14H,6-7H2,1H3,(H,15,16)/t9-/m1/s1
  • Key:HNDPIXZRQWKEFZ-SECBINFHSA-N

(R)-69也稱為3IQ是一種含氮有機化合物,分子式C
13
H
15
N
3
,屬於色胺的類似物,由布萊恩·L·羅斯英語Bryan Roth及其同事在2022年為5-HT2A受體激動劑研發,可作為迷幻藥物[1][2]

參考文獻[編輯]

  1. Duan W, Cao D, Wang S, Cheng J. Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants. Chemical Reviews. January 2024, 124 (1): 124–163. PMID 38033123. doi:10.1021/acs.chemrev.3c00375. Very recently, the docking of a bespoke tetrahydropyridines (THPs) library combined with a structure-based optimization approach by Kaplan et al. led to the discovery of novel 5-HT2AR agonists with antidepressant activity in mouse models.202 The docking of a virtual library of 75 million THP compounds against the model of 5-HT2AR yielded 17 initial hits, among which 4 compounds showed low-micromolar activities at either 5-HT2AR or 5-HT2BR. Further modifications afforded [...] compounds (R)-69 (170) and (R)-70 (171) as agonists (Ki = 680 and 880 nM; EC50 = 41 nM (90.1%) and 110 nM (73.3%) in the calcium flux assay, respectively) (Figure 14D). Both compounds showed moderate binding selectivity against the 5-HT2BR and 5-HT2CR, and overall better selectivity profiles than those of classic psychedelic 5-HT2AR agonists. Interestingly, compounds (R)-69 and (R)-70 were pharmacologically profiled as G protein-biased 5-HT2AR agonists and were demonstrated as nonhallucinogenic in the HTR test and could block LSD-induced HTR effects. Very importantly, the compounds exhibited both acute and lasting (at least over 24 h) antidepressant effects in several mouse behavioral models.202 
  2. Kaplan AL, Confair DN, Kim K, Barros-Álvarez X, Rodriguiz RM, Yang Y, Kweon OS, Che T, McCorvy JD, Kamber DN, Phelan JP, Martins LC, Pogorelov VM, DiBerto JF, Slocum ST, Huang XP, Kumar JM, Robertson MJ, Panova O, Seven AB, Wetsel AQ, Wetsel WC, Irwin JJ, Skiniotis G, Shoichet BK, Roth BL, Ellman JA. Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. Nature. October 2022, 610 (7932): 582–591. Bibcode:2022Natur.610..582K. PMC 9996387可免費查閱. PMID 36171289. S2CID 252598838. doi:10.1038/s41586-022-05258-z. 

外部連結[編輯]